Skip to main content

People in the News: Keith Elliston, Michael Braxenthaler, Brian Athey, and Kevin Smith

Premium

The TranSMART Foundation has made several changes to its management team.

The foundation has selected Keith Elliston to serve as its CEO and president. Previously, he was the foundation's chief science officer and head of business development. He is also president of Seneca Creek Research.

Elliston will be taking over from co-CEO's Michael Braxenthaler and Brian Athey, who will take on the roles of vice president of industry relations and chief science officer respectively. Braxenthaler is also president of the Pistoia Alliance and global head strategic alliances for Roche, while Athey is professor and chair of the department of computational medicine and bioinformatics at the University of Michigan's medical school.

Meanwhile, Kevin Smith, who was previously the executive director of the foundation will now serve as community manager and secretary. He is also director of UM's medical school.

Filed under

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.